• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特别关注湖南省长沙县孕妇中α地中海贫血和β地中海贫血的患病率。

A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province.

作者信息

Xia Yu, Huang Cailian, Yang Mudan, Zhang Meng, Lu Yang

机构信息

Department of obstetrics and gynecology, Changsha County maternal and child health hospital, Changsha, Hunan, China.

出版信息

Front Genet. 2024 Nov 7;15:1422462. doi: 10.3389/fgene.2024.1422462. eCollection 2024.

DOI:10.3389/fgene.2024.1422462
PMID:39574796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11578977/
Abstract

BACKGROUND

Thalassemia is a inherited monogenic blood disorder and more prevalent in southern China. In this study, Our aim was to elucidate the molecular spectrum and phenotypic features of thalassemia in pregnant women in Changsha County.

METHODS

Next-generation sequencing (NGS) was conducted for 38,810 pregnant women to diagnose thalassemia in Changsha County. Further analysis of hematological parameters was conducted on subjects who had not previously undergone thalassemia screening in other hospitals.

RESULTS

In this study, 2,208 (5.69%) pregnant women were diagnosed as carriers of thalassemia using NGS analysis. Among 1,594 cases of α-thalassemia, 23 genotypes were identified, and among 578 cases of β-thalassemia, 22 genotypes were detected. Additionally, 18 genotypes were detected among 36 cases of composite α- and β-thalassemia. Among all carriers of thalassemia, 8 rare α-mutations and 11 rare β-mutations were found in the study population. Notably, pregnant women diagnosed as carriers of thalassemia tended to have lower hemoglobin levels. Furthermore, multivariable logistic regression analysis indicates that the values of MCV and MCH have the greatest impact on genetic diagnosis.

CONCLUSION

Our study has provided detailed genotypes and hematological parameters of thalassemia in pregnant women in Changsha county and reveal that certain abnormal blood parameters have a remarkably impact on genetic diagnosis results. Furthermore, our data suggest that combining hemoglobin electrophoresis and NGS provides a powerful tool for prenatal diagnosis, which will increase the accuracy of clinical diagnosis of thalassemia.

摘要

背景

地中海贫血是一种遗传性单基因血液疾病,在中国南方更为普遍。在本研究中,我们的目的是阐明长沙县孕妇地中海贫血的分子谱和表型特征。

方法

对38810名长沙县孕妇进行下一代测序(NGS)以诊断地中海贫血。对之前未在其他医院进行过地中海贫血筛查的受试者进一步分析血液学参数。

结果

在本研究中,通过NGS分析诊断出2208名(5.69%)孕妇为地中海贫血携带者。在1594例α地中海贫血病例中,鉴定出23种基因型,在578例β地中海贫血病例中,检测到22种基因型。此外,在36例复合α和β地中海贫血病例中检测到18种基因型。在所有地中海贫血携带者中,研究人群中发现了8种罕见的α突变和11种罕见的β突变。值得注意的是,被诊断为地中海贫血携带者的孕妇血红蛋白水平往往较低。此外,多变量逻辑回归分析表明,MCV和MCH值对基因诊断影响最大。

结论

我们的研究提供了长沙县孕妇地中海贫血的详细基因型和血液学参数,并揭示某些异常血液参数对基因诊断结果有显著影响。此外,我们的数据表明,结合血红蛋白电泳和NGS为产前诊断提供了有力工具,这将提高地中海贫血临床诊断的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/8cb137e5f9a9/fgene-15-1422462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/7e3cd6e2f0fb/fgene-15-1422462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/51937c8c3921/fgene-15-1422462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/8cb137e5f9a9/fgene-15-1422462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/7e3cd6e2f0fb/fgene-15-1422462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/51937c8c3921/fgene-15-1422462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6636/11578977/8cb137e5f9a9/fgene-15-1422462-g003.jpg

相似文献

1
A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province.特别关注湖南省长沙县孕妇中α地中海贫血和β地中海贫血的患病率。
Front Genet. 2024 Nov 7;15:1422462. doi: 10.3389/fgene.2024.1422462. eCollection 2024.
2
The prevalence and outcomes of α- and β-thalassemia among pregnant women in Hubei Province, Central China: An observational study.华中地区湖北省孕妇中α-和β-地中海贫血的患病率和结局:一项观察性研究。
Medicine (Baltimore). 2022 Mar 4;101(9):e28790. doi: 10.1097/MD.0000000000028790.
3
Next-generation sequencing analysis of the molecular spectrum of thalassemia in Southern Jiangxi, China.中国赣南地区地中海贫血症分子谱的新一代测序分析。
Hum Genomics. 2023 Aug 17;17(1):77. doi: 10.1186/s40246-023-00520-5.
4
[Thalassemia Gene Detection Results and Application Value of Hematological Indexes Among Pregnant Women in Xindu District of Chengdu City].[成都市新都区孕妇地中海贫血基因检测结果及血液学指标的应用价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Apr;30(2):543-546. doi: 10.19746/j.cnki.issn.1009-2137.2022.02.037.
5
Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China.中国南方广东省东莞市地中海贫血的分子流行病学和血液学特征。
J Clin Lab Anal. 2021 Feb;35(2):e23596. doi: 10.1002/jcla.23596. Epub 2020 Sep 28.
6
[A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].云南省人群α和β地中海贫血基因突变谱及产前基因诊断研究
Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):85-9.
7
Molecular prevalence of -associated hemoglobinopathy among reproductive-age adults and the prenatal diagnosis in Jiangxi Province, southern central China.中国中南部江西省育龄成年人中与 - 相关血红蛋白病的分子流行情况及产前诊断
Front Genet. 2022 Sep 28;13:992073. doi: 10.3389/fgene.2022.992073. eCollection 2022.
8
Prevalence and spectrum of thalassaemia in Changsha, Hunan province, China: discussion of an innovative screening strategy.中国湖南省长沙市地中海贫血的患病率及谱系:一种创新筛查策略的探讨
J Genet. 2017 Jun;96(2):327-332. doi: 10.1007/s12041-017-0779-6.
9
Clinical experience using peripheral blood parameters to analyse the mutation type of thalassemia carriers in pregnant women.利用外周血参数分析孕妇地中海贫血携带者突变类型的临床经验。
J Obstet Gynaecol. 2023 Dec;43(1):2195490. doi: 10.1080/01443615.2023.2195490.
10
[Application of Next-Generation Sequencing in Screening of Thalassemia Gene in 11212 Pregnant Women in Suxian and Beihu Districts of Chenzhou City, Hunan Province].[下一代测序技术在湖南省郴州市苏仙区和北湖区11212例孕妇地中海贫血基因筛查中的应用]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Feb;29(1):188-192. doi: 10.19746/j.cnki.issn.1009-2137.2021.01.029.

本文引用的文献

1
[Expert consensus on clinical genetic counseling of α-thalassemia gene analysis].α地中海贫血基因分析临床遗传咨询专家共识
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Jun 10;41(6):669-676. doi: 10.3760/cma.j.cn511374-20240131-00079.
2
Next-generation sequencing analysis of the molecular spectrum of thalassemia in Southern Jiangxi, China.中国赣南地区地中海贫血症分子谱的新一代测序分析。
Hum Genomics. 2023 Aug 17;17(1):77. doi: 10.1186/s40246-023-00520-5.
3
CRISPR Therapeutics, Vertex Complete Rolling Biologics License Applications for Exa-Cel in Sickle Cell Disease, Beta Thalassemia.
CRISPR Therapeutics公司和福泰制药完成了针对治疗镰状细胞病和β地中海贫血的Exa-Cel的滚动生物制品许可申请。
Hum Gene Ther. 2023 May;34(9-10):341-344. doi: 10.1089/hum.2023.29241.bfs.
4
The role of molecular diagnostic testing for hemoglobinopathies and thalassemias.血红蛋白病和地中海贫血症的分子诊断检测的作用。
Int J Lab Hematol. 2023 Jun;45 Suppl 2:71-78. doi: 10.1111/ijlh.14089. Epub 2023 May 21.
5
A Particular Focus on the Prevalence of - and -Thalassemia in Western Sicilian Population from Trapani Province in the COVID-19 Era.特别关注 COVID-19 时代来自特拉帕尼省的西西里西部地区人群中 - 地中海贫血症和 - 地中海贫血症的患病率。
Int J Mol Sci. 2023 Mar 2;24(5):4809. doi: 10.3390/ijms24054809.
6
Molecular prevalence of -associated hemoglobinopathy among reproductive-age adults and the prenatal diagnosis in Jiangxi Province, southern central China.中国中南部江西省育龄成年人中与 - 相关血红蛋白病的分子流行情况及产前诊断
Front Genet. 2022 Sep 28;13:992073. doi: 10.3389/fgene.2022.992073. eCollection 2022.
7
The hemoglobinopathies, molecular disease mechanisms and diagnostics.血红蛋白病,分子发病机制与诊断。
Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):28-36. doi: 10.1111/ijlh.13885.
8
Molecular Spectrum, Ethnic and Geographical Distribution of Thalassemia in the Southern Area of Hainan, China.中国海南南部地区地中海贫血的分子谱、种族及地理分布
Front Pediatr. 2022 Jun 10;10:894444. doi: 10.3389/fped.2022.894444. eCollection 2022.
9
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022.造血细胞移植治疗血液系统疾病、实体瘤和免疫性疾病的适应证:2022 年欧洲的现行实践。
Bone Marrow Transplant. 2022 Aug;57(8):1217-1239. doi: 10.1038/s41409-022-01691-w. Epub 2022 May 19.
10
β-Thalassemias.β地中海贫血
N Engl J Med. 2021 Feb 25;384(8):727-743. doi: 10.1056/NEJMra2021838.